Related Experiment Videos
PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study
Journal of Neuro-Oncology
|January 1, 1986
Abstract:
Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase II trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.
Journal of thrombosis and haemostasis : JTH·2016
Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta.
Genetics in medicine : official journal of the American College of Medical Genetics·2015
DETECTION OF LACTOBACILLI IN MONTHLY MAIL-IN STOOL SAMPLES FROM 3-18 MONTHS OLD INFANTS AT GENETIC RISK FOR TYPE 1 DIABETES.
International journal of probiotics & prebiotics·2014
Pruritic acquired nevus of Ota.
Dermatology (Basel, Switzerland)·2013
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
Diabetes/metabolism research and reviews·2011
Stereotactic body radiation therapy in elderly patients with spinal metastases.
Journal of neuro-oncology·2026
Long term outcomes and predictors of recurrence in central neurocytomas: a 35-year multi-institutional experience.
Journal of neuro-oncology·2026
Integrated models of palliative medicine and pain management for the treatment of cancer-related pain: a review.
Current opinion in supportive and palliative care·2026
The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function.
Molecular therapy : the journal of the American Society of Gene Therapy·2026